- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avacta Group PLC (AVCT)
Assess today's latest current Avacta Group PLC (AVCT) share price, performance and insights using our live LON: AVCT stock exchange data.
Avacta Group plc (lon: avct) is a British biotechnology company focused developing send selling diagnostic and therapeutic solutions. Avacta's technology has multi-area application, including cancer diagnostics, infectious diseases, and autoimmune conditions. The company also collaborates with partners for the development and commercialisation of its products.
Analyse historical data and avct share price performance charts on this page. Our technical summary section provides analysis on Avacta stock price buy/sell indicators using real-time data. Use the dropdown to select a relevant stock exchange for the current NASDAQ stock or LON: AVCT share price (ISIN: GB00BYYW9G87) to enhance your trading decisions with our freely provided resources.
Avacta Group plc (lon: avct) is a British biotechnology company focused developing send selling diagnostic and therapeutic solutions. Avacta's technology has multi-area application, including cancer diagnostics, infectious diseases, and autoimmune conditions. The company also collaborates with partners for the development and commercialisation of its products.
Analyse historical data and avct share price performance charts on this page. Our technical summary section provides analysis on Avacta stock price buy/sell indicators using real-time data. Use the dropdown to select a relevant stock exchange for the current NASDAQ stock or LON: AVCT share price (ISIN: GB00BYYW9G87) to enhance your trading decisions with our freely provided resources.
London
Currency in GBP
59.50
-2.00(-3.25%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.00
63.00
52 wk Range
26.00
84.00
AVCT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.0063.00
52 wk Range
26.0084.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AVCT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
80.00
Upside
+34.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Neutral
Moving Averages
Strong Buy
Avacta Group Company Profile
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.
Compare AVCT to Peers and Sector
Metrics to compare | AVCT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVCTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.7x | −3.5x | −0.5x | |
PEG Ratio | 0.09 | −0.09 | 0.00 | |
Price/Book | 1,883.3x | 3.8x | 2.6x | |
Price / LTM Sales | 2,399.9x | 12.0x | 3.3x | |
Upside (Analyst Target) | 40.8% | 169.1% | 44.3% | |
Fair Value Upside | Unlock | 0.2% | 4.9% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 80.00
(+34.45% Upside)
Earnings
Latest Release
Sep 30, 2025
EPS / Forecast
-0.04 / --
Revenue / Forecast
56.00K / --
People Also Watch
FAQ
What Is the Avacta Group (AVCT) Share Price Today?
The live Avacta Group share price today is 59.50
What Stock Exchange Does Avacta Group (AVCT) Trade On?
Avacta Group is listed and trades on the London Stock Exchange.
What Is the Ticker (Stock Symbol) for Avacta Group?
The stock symbol (also called a 'ticker') for Avacta Group is "AVCT."
What Is the Current Avacta Group Market Cap?
As of today, Avacta Group market capitalisation is 260.26M.
What Is Avacta Group's (AVCT) Earnings Per Share (TTM)?
The Avacta Group EPS is currently -0.11 (Trailing Twelve Months).
When Is the Next Avacta Group Earnings Date?
Avacta Group's next earnings report will be released on 15 Apr 2026.
Is AVCT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Avacta Group moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Avacta Group Stock Split?
Avacta Group has split 1 times. (See the AVCT stock split history page for full effective split date and price information.)
How Many Employees Does Avacta Group Have?
Avacta Group has 151 employees.
What is the current trading status of Avacta Group (AVCT)?
As of 11 Feb 2026, Avacta Group (AVCT) is trading at a price of 59.50, with a previous close of 59.50. The stock has fluctuated within a day range of 59.00 to 63.00, while its 52-week range spans from 26.00 to 84.00.
What Is Avacta Group (AVCT) Price Target According to Analysts?
The average 12-month price target for Avacta Group is GBP80.00, with a high estimate of GBP106 and a low estimate of GBP43. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +34.45% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.